191 related articles for article (PubMed ID: 19293566)
1. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
Helisalmi S; Väkevä A; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Guarnieri BM; Bartoli A; Serio A; Piacentini S; Sorbi S
Neurosci Lett; 2006 Jan; 392(1-2):110-3. PubMed ID: 16188386
[TBL] [Abstract][Full Text] [Related]
3. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
[TBL] [Abstract][Full Text] [Related]
4. Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease.
Chuo LJ; Sheu WH; Pai MC; Kuo YM
Dement Geriatr Cogn Disord; 2007; 23(4):251-7. PubMed ID: 17310123
[TBL] [Abstract][Full Text] [Related]
5. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
[TBL] [Abstract][Full Text] [Related]
6. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
7. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
8. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
Lamsa R; Helisalmi S; Herukka SK; Tapiola T; Pirttila T; Vepsalainen S; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2007; 24(2):146-50. PubMed ID: 17622762
[TBL] [Abstract][Full Text] [Related]
9. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
10. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F
Eur J Hum Genet; 2001 Jun; 9(6):464-8. PubMed ID: 11436129
[TBL] [Abstract][Full Text] [Related]
11. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
12. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
Kamboh MI; Minster RL; Feingold E; DeKosky ST
Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
[TBL] [Abstract][Full Text] [Related]
13. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease.
Ahn Jo S; Ahn K; Kim JH; Kang BH; Kim E; Jo I; Kim DK
Clin Chim Acta; 2006 Jun; 368(1-2):179-82. PubMed ID: 16480703
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the cystatin C(CST3) gene G73A polymorphism and susceptibility to Alzheimer's disease.
Hua Y; Zhao H; Lu X; Kong Y; Jin H
Int J Neurosci; 2012 Aug; 122(8):431-8. PubMed ID: 22435454
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.
Pirskanen M; Hiltunen M; Mannermaa A; Helisalmi S; Lehtovirta M; Hänninen T; Soininen H
Eur J Hum Genet; 2005 Sep; 13(9):1000-6. PubMed ID: 15944651
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype in patients with Alzheimer's disease.
Luo B; Chen Z; Zhang Y; Pan X; Li X; Chen F
Chin Med J (Engl); 2003 Aug; 116(8):1220-2. PubMed ID: 12935416
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of methionine synthase gene 2756 A>G polymorphism and Alzheimer disease in a Chinese population.
Zhao HL; Li XQ; Zhang ZX; Bi XH; Wang B; Zhang JW
Brain Res; 2008 Apr; 1204():118-22. PubMed ID: 18329006
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
Koivisto AM; Helisalmi S; Pihlajamäki J; Moilanen L; Kuusisto J; Laakso M; Hiltunen M; Keijo K; Hänninen T; Helkala EL; Kervinen K; Kesäniemi YA; Soininen H
J Neurogenet; 2005; 19(3-4):155-61. PubMed ID: 16540406
[TBL] [Abstract][Full Text] [Related]
19. Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population.
Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
Psychiatr Genet; 2003 Jun; 13(2):85-90. PubMed ID: 12782964
[TBL] [Abstract][Full Text] [Related]
20. Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer's disease patients.
Hiltunen M; Mannermaa A; Koivisto AM; Lehtovirta M; Helisalmi S; Ryynänen M; Riekkinen P; Soininen H
Eur J Hum Genet; 1999 Sep; 7(6):652-8. PubMed ID: 10482953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
